BioSig Technologies (BSGM) announced that its subsidiary BioSig AI Sciences was selected to join NVIDIA Inception (NVDA), a program designed to partner with companies revolutionizing industries with advancements in artificial intelligence and data sciences. “We are thrilled to join an elite group of AI-centric technology companies leading the evolution of machine learning and AI across industries,” said Ken Londoner, Chairman, CEO and Founder of BioSig. “We believe NVIDIA Inception will help advance BioSig’s role in identifying transformational applications of AI opportunities in healthcare.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BSGM:
- BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
- BioSig Technologies joins Webull Corporate Connect
- BioSig Joins Webull Corporate Connect
- BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
- BioSig Technologies advances collaboration on machine learning, AI solutions